Biomolekuler Antimalaria Eurikumanon

Authors

Hanifah Yusuf
Kedokteran, Universitas Syiah Kuala

Synopsis

Buku ini membahas malaria dalam kaitannya dengan tantangan dan peluang untuk menemukan dan mengembangkan senyawa baru dari bahan alam sebagai antimalaria, sehingga dapat membantu mengatasi permasalahan resistensi Plasmodium yang semakin meluas. Buku ini untuk pengembangan pengetahuan tentang upaya preventif malaria berbasis bahan alam yang menggambarkan secara molekuler peran Eurikumanon yang terlibat pada pathogenesis pengobatan malaria. Hadirnya buku ini mengajak pembaca akan meningkatkan inovasi dan motivasi untuk mencari pola baru dalam menuntaskan malaria berbasis bahan alam.

Author Biography

Hanifah Yusuf, Kedokteran, Universitas Syiah Kuala

Dr. Hanifah Yusuf, M.Kes, Apt is one of the teaching staff at the Department of Pharmacology of the Faculty of Medicine, Syiah Kuala University Banda Aceh Indonesia. In addition to teaching at the Faculty of Medicine also teaches in the Pharmacy Program of the Faculty of Mathematics and Natural Sciences and the Faculty of Nursing University of Syiah Kuala. Born in Banda Aceh on September 11, 1957, undergraduate education at the Department of Pharmacy FMIPA USU (1984), Professor of Pharmacist (1985). In 2001 he completed his S-2 majoring in Biomedical, a field of Pharmacology study, and on January 10, 2014, he completed his Doctoral degree in Medical and Health Sciences at the Faculty of Medicine, Gadjah Mada University, Yogyakarta.

References

Sutanto, I., Ismid, I.S., Syarifuddin, P.K., and Sungkar, S. 2008. Parasitologi Kedokteran. Edisi Ke-empat. Balai Penerbit Fakultas Kedokteran Universitas Indonesia, Jakarta.

Sandjaja, B. 2007. Protozoologi Kedokteran. Buku 1. Prestasi Pustaka Publisher. Jakarta.

Mulyaningsih, B., and Sudarsono. 2001. Penentuan Aktivitas Antimalaria Minyak dari Biji Mimba (Azadirachta indica A Juss) yang Diberikan Per- Oral pada Hewan Uji Mencit. Jurnal Kedokteran Yarsi 9 (3): 17-24.

Hoffman, S.L., Campbell, C.C., and White, N.J. 2004. Malaria. Nature 1024-1061.

Dale, P., Sipe, N., Sugianto., Hutajulu, B., Ndoen, E., Papayungan, M., Saikhu, A., and Tri Prabowo, Y. 2005. Malaria in Indonesia: A Summary of Recent Research into Its Environmental Realtionships. Southeast Asian Journal of Tropical Medicine Public Health. 1-11.

Laihad, F.J., and Gunawan, S. 2000. Malaria di Indonesia, dalam Harijanto, P.N: Malaria, Epidemiologi, Patogenesis, Manifestasi Klinis dan Penanganan. Penerbit Buku Kedokteran EGC Jakarta.

CDC-Centers for Disease Control and Prevention. 2008. The Impact of Malaria, a Leading Cause of Death Worldwide. Available from: http:// www.cdc.gov/malaria/index.htm.

Harijanto, P.N. 2000. Malaria, Epidemiologi, Patogenesis, Manifestasi Klinis dan Penanganan. Penerbit EGC, Jakarta . 1-16.

del Portillo HA, Ferrer M, Brugat T, MartinJaular L, Langhorne J, Lacerda MVG. The role of the spleen in malaria. Cell Microbiol. 2012; 14(3):343-355.

Engwerda CR, Beattie L, Amante FH. The importance of the spleen in malaria. Trends Parasitol. 2005; 21(2): 75-80

Egan, T.J. 2004. Haemozoin Formation as A Target For The Rational Design of New Antimalarials. Drug Design Review 1 (1): 93–110.

Saikhu, A. 2002. Assessing The Environmental Risk Factors that Influence The Distribution of Malaria Prevalence in Central Java Province. School of Public Health, Griffith University, Australia. PhD Dissertation.

Syafruddin, D. 2006. Establishment of Malaria Surveillance for an Evidence-Based Malaria Control Program in Tsunami Affected Areas of Indonesia. Lembaga Biologi Eijkman, Jakarta

World Health Organization. 2001. Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation. World Health Organization Geneva, Switzerland

Winstanley, P., and Ward, S. 2006. Malaria chemotherapy. Advance Parasitology 61:47

Shapiro, T.A., and Goldberg, D.E. 2005: Drugs used in the chemotherapy of protozoal infections: Malaria, in Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 11th Ed. New York, McGraw-Hill

Tringali, C. 2001. Bioactive Compounds from Natural Sources. Taylor & Francis Group. London-New York.

Larsen, P.K., Liljefors, T., and Madsen, U. 1996. Drug Design and Development. 2nd Ed.. Harwood Academic Publisher.

Departemen Kesehatan RI. 2006. Pedoman Penatalaksanaan Kasus Malaria Di Indonesia. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan Lingkungan. Departemen Kesehatan Republik Indonesia, Jakarta.

World Health Organization. 2009. World Malaria Report . World Health Organization, Geneva

Chadijah, S., Labatjo, Y., Garjito, T.A., Wijaya, Y., and Udin, Y. 2006. Efektivitas Diagnosis Mikroskopis Malaria di Puskesmas Donggala, Puskesmas Lembasoda Dan Puskesmas Kulawi Provinsi Sulawesi tengah. Jurnal Ekologi Indonesia. 5: 385 – 394.

CIDA and UNICEF. 2009. Millenium Development Goals (Tujuan Pembangunan Milenium Mutlak Dicapai Tahun 2015). Perpustakaan AMPL.

Tjitra, E. 2003. Pengobatan Malaria dengan Kombinasi Artemisinin. Bulletin Penelitian Kesehatan 33 (2) : 53 – 61.

World Health Organization. 2000. Drug Resistance of Malarial Parasites . Expert Communication of Malaria Report. World Health Organization Geneva

Wiser, W.F. 2003. Mechanism of Drug Action and Resistance, http:// www.tulane.edu/-wiser/protozoology/notes/drugs/html

Basco, L.K., Lebras, J., Rhoades, Z., and Wilson, C.H.1994. Analysis of Pfmdr-1 and Drug Susceptibility in Fresh Isolates of Plasmodium falciparum from Sub Saharan Africa. Molecular Biochemistry Parasitology. 74: 157 – 166.

Fidock, D.A,. Nomura, T., Talley, A.K., Cooper, R.A., Dzeknov, S.M., and Ferdig, M.T. 2000. Mutation in The Plasmodium falciparum Digestive Vacuole Transmembrane Protein Pfcrt and Evidence for Their Role in Chloroquin Resistance. Molecular Cell. 6(4): 861-871.

Ridley, R.G . 2002 Medical Need, Scientific Opportunity and The Drive for Antimalarial Drugs. Nature 415, 686 – 693.

Krogstad, D.J., Gluzman, I.Y., Kyle, D.E., Oduola, A.M.J., Martin, S.K., Milhous, W.K., and Schlesing er, P.H. 1987. E fflux of Chloroquin from Plasmodium falciparum. Mechanism of Resistance . Science. 238 : 1283 – 1285

Achmad, M.F., dan Sutanto, I. 2003. Peran Gen Pfmdr-1 pada Mekanisme Resistensi Plasmodium falciparum Terhadap Klorokuin. Majalah Kedokteran Indonesia. 53 (2): 69-75.

Gazarini, M.L., Sigolo, C.A.O., Markus, R.P., Thomas, A.P., and Garcia, C.R.S. 2007. Antimalarial Drugs Disrupt Ion Homeostatis in Malarial Parasites. Memorial Institute Oswaldo Cruz, 102 (3): 329-334.

Grimberg, B.T., and Mehlotra, R.K. 2011. Expanding The Antimalarial Drug Now, But How. Pharmaceutical. 4: 681-712.

Gregson, A., and Plowe, C.V. 2005. Mechanism of Resistance of Malaria Parasites to Antifolates. Pharmacology Review. 57: 117-145.

Plowe, C.V. 2003. Monitoring Antimalarial Drug Resistance: Making The Most of Tools and Hand. Journal of Experimental Biology. 206: 3745-3752.

Ariey, F., Randrianarivelojosia, M., Duchemin, J.B., Rakatondramarina, D., Ouledi, A., Robert, V., Jambou, R., Jahevitra, M., Andrianantenaina, H., Raharimalala, L., and Mauclere, P. 2003. Mapping of a Plasmodium falciparum Pfcrt K76T Mutation: A Useful Strategy for Controlling Chloroquine Resiatance in Madagascar. Journal of Infection Disease. 185: 710-712.

Wangboonshul, J., White, N.J., Nosten, F., Terkutle, F., Moody, R.R., and Taylor, R.B. 1993. Single Dose Pharmakokinetic of Proguanil and Its Metabolite in Pregnancy. European Journal of Clinical Pharmacology. 44: 247-251.

Wathen, W.M., Mac, E.K., Nevill, C.G., Ward, S.A., Brehenridge, A.M and Koech, D.K. 1990. Variability in The Metabolism of Proguanil to The Active Metabolite Cycloguanil in Healthy Kenyan Adults. Transmission Reseach Social Tropical Medicinal Hygiene. 84: 492 – 495. .

White, N.J., Nosten, F., Looaresuwan, S., Watkins, W.M., Marsh, K. Snow, R.W., Kokwaro, G., Ohma, J., Hien, J., Molyneux, M.E., Taylor, T.E., Newbold, C.L., Ruebush, C.K., Danush, M. Greenwood, B.M., Anderson, R.M., and Olliaro, P. 1999. Averting a Malaria Disaster. Lancet. 353: 1965- 1967.

Kalra, B.S., Chawla, S., Gupta P., and Valecha, N. 2006. Screening of Antimalarial Drugs: An Overview. Indian Journal of Pharmacology. 38 (1): 5-12.

Gelb, M.H. 2007. Drug Discovery for Malaria: A Very Challenging and Timely Endeavor. Current Opinion in Chemical Biology. 11: 440-445.

Rosenthal, J.P. 2003. Review Antimalarial Drug Discovery: Old and New Approaches. Journal of Experimental Biology. 206: 3735 - 3744.

Goldberg, D.E. 2005. Haemoglobin Degradation. Current Tropical Microbioliogy Immunology. 295: 275-291.

Hudson, T., Kopydlowski, K., and Bhattacharjee, A. 2009. Target Directed Drug Discovery: A Technology Driven Approach to Combating Malaria. 1-7.

Kumar, S., Guha, M., Choubey, V., Maity, P., and Bandyophadhay, U. 2007. Antimalaria lDrugs Inhibit ing Hemozoin (β-hem atin) Formation: A Mechanistic Update. Life Science. 80: 813 – 828

Spiller, D.G., Bray, P.G., Hugher, R.H., Ward, S.A., and White, M.R. 2002. The pH of The Plasmodium falciparum Digestive Vacuole: Holy Grail or Dead End Trail. Trends in Parasitology. 18: 441 – 444.

Gutteridge,W.E. 1997. Designer Drugs: Pipe Dreams or Realities. Parasitology 114, 145-151.

Hunter, W.N.1997. A Structure Based Approach to Drug Discovery, Chrystallography and Implication for the Development of Antiparasitic Drugs. Parasitology 114:179- 190.

Hunter, W.N.1997. A Structure Based Approach to Drug Discovery, Chrystallography and Implication for the Development of Antiparasitic Drugs. Parasitology 114:179- 190.

Li, Z., Chen, X., Davidson, E., Zwang, O., Mendis, C., Ring, C.S., Roush, W.R., Fegley, G., Li, R., Rosenthal, P.J., Lee, G.K., Kenyon, G.L., Kunzt, L.D., and Cohen, F.E. 1994. Antimalarial Drug Development Using Model of Enzym Structure. Chemical Biology. 1: 31-37.

Cohen, F.E., McKerrow, J.H., Li, Z., Chen, X., and Gong, B. 1997. Inhibitor of Metazoan Parasite Protease. US Paten. PCY/US96/03445, 1-23. 1997. USA. Ref Type: Patent.

Dominguez, J.N., Lopes, S., Charris, J., Iarruso, L., Lobo, G., Semenov, A., Olson, J.E., and Rosenthal, P.J. 1997. Synthesis and Antimalarial Effect of Phenothiazine Inhibitors of Plasmodium falciparum Cystein Protease. Journal of Medicinal Chemistry. 40: 22726-2732.

Ziegler, J., Linck, R., Wright, D.W. 2001. Haem Aggregation Inhibitors: Antimalarial Drugs Targetting An Essential Biomineralization Process. Current Medicinal Chemistry. 8 (2): 171 – 189.

Campanale, N., Nickle, C., Daubenberger, C.A., Wehlan, D.A., Gorman, J.J , Kloni s, N., Bec ker , K ., and Tilley, L. 2003. Identification and Characterization of Haem-Interacting Proteins in The Malaria Parasites Plasmodium falciparum. Journal of Biological Chemistry. 278 (30): 27354 – 27361

Schmitt, T.H., Frezzatti, J.W.A., and Schreirer, S. 1993. Haem Induced Lipid Membran Disorder and Increased Permeability: A Molecular Model for The Mechanism of Cell Lysis. Archieves of Biochemistry and Biophysics 307 (1) 96 – 103.

Becker, K., Tilley, L., Vennerstrom, J.L., Robert, D., Rogerson, S., and Ginsburg, H. 2004. Oxidative Stress in Malaria Parasite-Infected Erythrocytes: Host Parasite Interaction. Internatinal Journal for Parasitology. 34 (2): 163-189.

Muller, S. 2004. Redox and Antioxidant System of The Malarial Parasite Plasmodium falciparum. Molecular Biology. 53: 1291-1305.

Tekwani, B.I., and Walker, L.A. 2005. Targetting The Hemozoin Synthesis Pathway for New Antimalarial Drug Discovery: Technology for In Vitro Beta-Hematin formation Assay. Combinatorial Chemistry and High Throughput Screening. 8 (1) : 63-79.

Hyde, J.E., Dittrich, S., Wang, P., Sims, P.F., and Crecy-Lagard, V. 2008. Plasmodium falciparum: A Paradigm for Alternative Folate Biosynthesis in Diverse Microorganisms?. Trends in Parasitology. 24 (11): 502-508.

Yuthavong, Y., Yuvaniyama, J. Chitnumsub, P. 2005. Malarial (Plasmodium falciparum) Dihydrofolate Reductase-Thymidylate Synthase: Structural Basis for Antifolate Resistance and Development of Effective Inhibitors. Parasitology 130: 249-259.

Wiwantikit, V. 2007. Plasmodium and Host Lactate Dehydrogenase Molecular Function and Biological Pathways: Implication for Antimalarial Drug Discovery. Chemical Biology Drug Development. 69 (4): 280–283.

Chan, K.L., Chooa, Y.C., Abdullah, N.R., and Ismail, Z. 2004. Antiplasmodial Studies of Eurycoma longifolia, Jack. Using The Lactate Dehydrogenase Assay of Plasmodium falciparum. Journal of Ethnopharmacology. 92: 223–227.

Dunn, C.R. , Banfiel d, M. J., Bar ker, J.J., H igham , C.W., Moret on, K.M., Turgut, B.D., Brady, R.L., and Hollbrock, J.J. 1996. The Structure of Lactate dehydrogenase from Plasmodium falciparum Reveals a New Target for Antimalarial Drugs Design. Nature. Structural Biology. 3, 912 – 915.

Keough, D.T., Ng, A.L., Winzor, D.J., Emmerson, B.T and Dejersey, J. 1999 . Purificati on and Characteriza ti on of Plasmodium falciparum Hypoxanthine-guanine-xanthine phosphoribosyltranferase and Comparison with the Human Enzyme. Molecular Biochemistry Parasitology. 98: 29 – 41.

Hazleton, K.Z., Chiaoho, M., Cassera, M.B., Clinch, K., Crump, D.R., Rosario, I., Merino, E.A., Almo, S.c., Tyler, P.C., and Schraum, V.L. 2012. Acyclic Immucillin Phosphonates: Second generation Inhibitors of Plasmodium falciparum Hypoxanthine Guanine Xanthine Phosphoribosyl Transferase. Chemistry and Biology. 19 (6): 721–730.

Vial, H.J., and Calas, M. 2001. Inhibitor Of Phospholipid Metabolism. In Antimalarial Chemotherapy: Mechanism Of Action, Resistance, and New Directions in Drug Discovery. Humana Press. Totowa, NJ

Choubey,V., Maity, P.,Guha,M., Kumar, S., Srivastava, K., Puri, S.K., and Bandyopadhyay, U. 2007. Inhibition of Plasmodium falciparum Choline Kinase by Hexadecyltrimethylammonium Bromida: A Possible Antimalarial Mechanism. Journal of Antimicrobial Agents and Chemotherapy. 51 (2): 696-706.

James, G.B., Peter, A., Winstanley., Geoffrey, I., McFadden,. and Graham, V.B. 2001. New Agents to Combat Malaria. Nature Medicine 7, 149–150.

Silvia, C.T., Nectarios, K., Sandra, D., Leonardo, L., Vicky, M.A., Craig, A.H., Jonathan, B.B., and Leand, T. 2013. Novel Conyugated Quinoline-Indoles Compromise Plasmodium falciparum Mitochondrial Function and Show Promising Antimalarial Activity. Journal of Medicinal Chemistry. 56 (15): 6200–6215.

Vaidya, A.B. 2001. Atavaquone-Proguanil Combination. In Antimalarial Chemotherapy: Mechanism Of Action, Resistance, and New Directions in Drug Discovery. Humana Press. Totowa, NJ

Alzeer, J. 2000. Phenyl Beta-Methoxyacrylates: A New Antimalarial Pharmacophore. Journal of Medical Chemistry. 43: 560–568

Foth, B.J., Stimmler, L.M., Handman, E., Crabb, B.S., Hodder, A.N., and McFadden, G.I. 2005. The Malaria Plasmodium falciparum Has Only Pyruvate Dehydrogenase Complex, Which is Located in The Apicoplast. Molecular Microbiology. 55 (1): 39-53.

Okamoto, N., Spurck, T.P., Goodman, C.D., and McFadden, G.I. 2009. Apicoplast and Mitochondrion in Gametocytogenesis of Plasmodium falciparum. Eukaryotic Cell. 8 (1): 128–132.

Surolia, N., and Surolia, A. 2001. Triclosan Offer Protection Against Blood Stages of Malaria by Inhibiting enoyl-ACP reduktase of Plasmodium falciparum . Nature Medicine, 7. 167–173

Phillipson, J.B., and Wright, C.W. 1991. Antiprotozoal Agents from Plant Sources. Planta Medica. 57: 53- 59.

World Health Organization. 2011a. Guidelines for the treatment of malaria, Second Edition. World Health Organization, Geneva

Posner, G.H., Paik, I.H., Sur, S., McRiner, A.J., Borstnik, K., Xie, S., and Shapiro, T.A. 2003. Orally Active Antimalarial, Anticancer, Artemisinin- Derived Trioxane Dimers with High Stability and Efficacy. Journal of Medicinal Chemistry. 46: 1060- 1065.

Mustofa. 2003. Molekul Antimalaria Alami: Potensi dan Tantangan Pengembangannya sebagai Obat Baru untuk Malaria. Majalah Obat Tradisonal. 8 (26): 8–18.

Kaur, K., Jain, M., Kaur, T., and Jain, R. 2009. Antimalarials from Nature. Bioorganic Medical Chemistry. 17: 3229-3256.

Guo, Z., Vangapandu, S., Sindelar, R.W., Walker, L.A., and Sindelar, R.D. 2005. Biologically Active Quassinoid and Their Chemistry: Potensial Leads for Drug Design. Current Medicinal Chemistry. 12: 190-193.

Roy, K., and Ojha, P.K. 2010. Advances in Quantitative Structure Activity Relationship Models of Antimalarials. Expert Opinion Drug Discovery. 5: 751-778.

Mason, J.S., Good, A.C., and Martin, E.J. 2001. Three Dimension Pharmacophore in Drug Discovery. Current Pharmacology. 7: 567– 597.

Debnath, A.K. 2001. Quantitative Structure Activity Relationship (QSAR) Paradigm Hansch Era to New millenium. Mini Review Medical chemistry. 1: 187.

Podlogar, B.L., and Ferguson, D.M. 2000. QSAR and CoMFA: A Perspective on The Practical Application to Drug Discovery. Drug Discovery. 17: 4–6.

Siswandono., and Soekardjo, B. 2000. Kimia Medisinal. Jilid 2. Edisi 2. Airlangga University Press, Surabaya.

Roy, K. 2007. On Some Aspects of Validation of Predictive Quantitative Structure-Activity Relationship Models. Expert Opinion Drug Discovery. 2 : 567–577.

Basak, S.C.., Mills, D., Hawkins, D.M., and Bhattacherjee, A.K. 2010. Quantitative Structure–Activity Relationship Studies of Antimalarial Compounds from Their Calculated Mathematical Descriptors. QSAR Environmental Research. 21: 103-125.

Kubinyi, H. 1993. QSAR: Hansch Analysis and Related Approaches, VCH Publisher, New York.

Naik, P. K., Sindhura, S.T., and Singh, H. 2009. QSAR for Insecticides : Development of Predictive In Vivo Insecticide Activity Models. QSAR environmental Research. 20 (5-6): 551-566..

Mustofa., an d Thahi r, I. 2 001. Hub ungan St ruktur Elek tro filik dan Aktivitas Antiplasmodial Senyawa Turunan Diaza Fenantren. Laporan Penelitian. Lembaga Penelitian Universitas Gadjah Mada Yogyakarta.

Hadanu, R. 2008. Desain, Sintesis dan Uji Aktivitas Antimalaria Senyawa Baru Turunan 1,10 Fenantrolin Melalui Pendekatan Analisis HKSA. Disertasi S3. Program Doktor Fakultas Matematik dan Ilmu Pengetahuan Alam.

Sastrohamidjojo, H. 2001. Kromatografi. Edisi ke-2. Penerbit Liberty, Yogyakarta.

Departemen Kesehatan RI. 1986. Sediaan Galenik. Jakarta. Direktorat Jenderal Pengawasan Obat dan Makanan.

Departemen Kesehatan RI. 2000. Parameter Standar Umum Ekstrak Tumbuhan Obat. Direktorat Jenderal Pengawasan Obat dan Makanan, Direktorat Pengawasan Obat Tradisional, Departemen Kesehatan Republik Indonesia, Jakarta.

Cannell, R.J.P. 1998. How to Approach The Isolation of a Natural Product. In: R.J.P Cannell (Ed), Methods in Biotechnology, Vol.4: Natural Products Isolation, Humana, Press, Totowa, New Jersey, USA, 1-51.

Qamariah, N., 2002. In vitro dan in vivo antiplasmodial activity of Eurycoma longifolia Jack., Tinospora tuberculata, Jack., Swietenia mahagoni, Jack and Azadirachta indica A. Jus. extracts. Unpublished thesis in partial fulfillment of the require ements for Master degree of biomedical sciences. Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Lee, V.T., and Nguyen, N.S.,1993. Constituents of Eurycoma longifolia, Jack. Journal of Organic Chemistry. 35: 1104-1109.

Itokawa, H., Qin, X.-R., Morita, H., Takeya, K., and Iitaka, Y. 1993. Novel Quassinoids from Eurycoma longifolia. Chemical and Pharmacology Bulletin. 41: 403-405.

Chan, K.L., O’Neill, M.J., Phillipson, J.D., and Warhurst, D.C. 1986. Plants as Source of Antimalarial Drugs. Part 3. Eurycoma longifolia. Planta Medica 52(2): 105–107.

Ang, H.H., Chan, K.L., and Mak, J.W. 1995. In Vitro Antimalarial Activity of Quassinoid from Eurycoma longifolia, Jack. Against Malaysian Chloroquine Resistant Plasmodium falciparum Isolates. Planta Medica. 61: 177-178.

Satayavivad, J., Soonthornchareonnon, N., Somanabandhu, A., and Thebtaranonth, Y. 1998. Toxicological and Antimalarial Activity of Eurycomalactone and Eurycoma longifolia Extract in Mice. Journal of Phytopharmacology. 5(2): 14-27.

Kuo, P.C., Damu, A.G., Lee, K.K., and Wu, T.S. 2004. Cytotoxic and Antimalarial Constituent from The Roots of Eurycoma longifolia, Journal of Bioorganic Medicinal Chemistry. 12: 537 -544.

Chan, K.L., Choo, C.Y., and Abdullah, N.R. 2005. Semisynthetic 15-O-acyl and 1,15-di-O-acyleurycumanone from Eurycoma longifolia, Jack. as Potential Antimalarials. Planta Medica. 71: 967– 969.

Ridzuan, M.A.R., Noor Rain, A., Zhari, I., and Zakiah, I. 2005. Effect of Eurycoma longifolia Jack Extract on The Glutathione Level in Plasmodium falciparum Infected Erythrocytes In Vitro. Tropical Biomedicine. 22: 155–163.

Kardono, L.B.S., Angerhofer, C.K., Tsauri, S., Padmawinata, K., Pezzuto, J.M., and Kinghorn, A.D., 1991. Cytotoxic and Antimalarial Constituents of The Roots of Eurycoma longifolia. Journal of Natural Product. 54: 1360-1367

Jiwajinda, S., Santisopasri, V., Murakami, A., Kawanaka, M., Kawanaka, H., Gasqult, M., Eilas, R., Balansard, G., and Ohigashi, H. 2002. In Vitro Antitumor Promoting and Antiparasitic Activities of The Quassinoids from Eurycoma longifolia A Medicinal Plant in Southeast Asia. Journal of Ethnopharmacology. 82: 55–58.

Yusuf, H., Mustofa, M. A. Wijayanti, R. A. Susisarti, P. B. X. Asih, Suryawati, Sofia . 201 3 . A New Quass in oid of Four Isolated Compounds from Extract Eurycoma longifolia, Jack Roots and Their in Vitro Antimalarial Activity. International Journal of Research in Pharmaceutical and Biomedical Sciences. 4: 728 – 734.

Omar, S., Zhang, J., MacKinnon, S., Leaman, D., Durst, T., Philogene, B.J.R., Arnason, J.T., Sanchez-Vindas, P.E., Poveda, L., Tamez, P.A., and Pezzuto, J.M. 2003. Traditionally-Used Antimalarials from the Meliaceae. Current Medicinal Chemistry. 3: 137-139.

Trager, W., and Jensen, J.B. 1976. Human Malaria Parasites in Continous Culture. Science 193 (4254): 673 –675.

Rieckman, K. H., Sax, L.J., Campbell, G.H., and Meremo, J.E. 1978. Drug Sensitivity of Plasmodium falciparum In Vitro Microtechnique. Lancet 311: 22-23.

Freshney, I.R. 2000. Culture of Animal Cells: A Manual of Basic Techniques. 4th Ed. A John Willey and Sons, Inc. Publishing, New York. USA

World Health Organization. 1987. The Biology of Malaria Parasites. Technical Report Series 743, Geneva.

Kupchan, S.M., Fessler, D.C., Eakin, M.A., and Giacobbe, T.J. 1970. Reaction of Alpha Methylen Lactone Tumor Promoter Inhibitors with Model Biological Nucleophiles. Science 168, 376–377.

Kirby, G.C., O’Neill, M.J., Phillipson, J.D., and Warchust, D.C. 1989. In Vitro Studies on The Mode of Action of Quassinoids with Activity Against Chloroquine-resistant Plasmodium falciparum. Biochemical Pharmacology. 38: 4367–4374.

Kar, A. 2004. Advanced Practical Medicinal Chemistry. New Age International Publisher, New Delhi.

Rahman, N.N.N.A., Furuta, T., Kojima, S., Takane, K., and Mohd, M.A., 1999. Antimalarial Activity of Extracts of Malaysian Medicinal Plants. Journal Of Ethnopharmacology. 64: 249–254.

Kupchan, S.M., Britton, R.W., Lacadie, J.A., Ziegler, M.F., and Siegel, C.W.J. 1975. The Isolation and Structural Elucidation of Bruceantin and Bruceantinol, New Potent Antileukemic Quassinoids from Bruceae antidysenterica. Journal Organic Chemistry 40: 648–654.

Teh, C. H., Teoh, S. C. , Yeap, C. S. Chan, K. L., and Fun, H.K. 2009. 4,5,7,8,17-Pentahydroxy-14,18-dimethyl-6-methylene-3,10- dioxapentacyclo 9.8.0.01,7.04,19.013,18]nonadec,14-ene-9,16- dione methanol solvate dihydrate. Acta Crystallographica. 65: 898– 899.

Sastrohamidjojo, H., and Pranowo, H.D. 2009. Sintesis Senyawa Organik. Penerbit Erlangga. Jakarta.

Sarker, S.D., and Nahar, L. 2007. Chemistry for Pharmacy Student: General Organic and Natural Product Chemistry. John Wiley & Son Ltd, England.

Tada, H., Shiho, O., Kuroshima, K., Koyama, M., and Tsukamoto. 1986. An Improved Colorometric Assay for Interleukin-2. Journal of Immunology Method. 93 (2): 157-165.

Sholikhah, E. N., Wijayanti, M. A., Susidarti, R. A., Purwantini, I., Hestiyani, R. A. N., Yusuf, H &, M (20 16). Stage Specificity of Eurycomanone Isolated from Eurycoma longifolia on Plasmodium falciparum Cycles. American Journal of Pharmacology and Toxicology, 11(1), 1-7.

Yusuf H, Mustofa, Wijayanti, Susidarti. SEMISYNTHESIS AND BIOLOGICAL EVALUATION OF EURYCOMANONE DERIVATIVES AS NEW ANTIMALARIAL. Int. Res J Pharm. App Sci., 2013; 3(6):4-7

Mawaddah, R .D .,Meut ia, F., Sofia, & Yusuf, H. (2013). THE ACUTE TOXICITY OF METHANOLIC EXTRACT OF EURYCOMA LONGIFOLIA JACK ROOTS AND HISTOPATHOLOGIC CHANGES OF RAT VITAL ORGANS. International Research Journal of Pharmaceutical and Applied Sciences, 3(3), 13-17.

Santos SC, Santos SP, Solevilla CR. Phytochemical, Microbiological and Pharmacological Screening of Medical Plants, 1978. GMS Publishing Corp. Manila. 1978, p37-55.

Hanifah Y, Maryatun, Darma S, 2016. Antimalarial activity of parenteral administration of eurycomanone-artesunate combination in Plasmodium berghei infected mice. Journal of Chemical and Pharmaceutical Research, 2016, 8(2):18-22

Roy A . and Sara f S. 2006.Limo noids: Ove rview of significant bioactive triterpenes distributed in Plants Kingdom. Biol.Pharm. Bull 29 (2): 191-201.

Biswas K, Chattopadhyay I, Banerjee RK, Badyopadhyay U; Current Science., 2002; 82 (11): 1336-1345.

Hanifah Yusuf, Suryawati, & Aulia Risti, U. M. (2012). ANTIMALARIAL ACTIVITY OF HEXANE EXTRACT OF NEEM LEAVES (AZADIRACHTA INDICA A.JUSS) ON MICE (MUS MUSCULUS). International Research Journal of Pharmaceutical and Applied Sciences, 2(1), 1-10.

Freshney, I.R. 1990. Culture of Animal Cells. A Manual of Basic Technique. 2nd Ed. A John Wiley and Sons, Inc. Publishing: New York, USA.

Soemiati, A. 1998. Prospek Bioteknologi dan Pengujian Obat. Simposium dan Diskusi Panel Bioteknologi dan Kesehatan di Indonesia. Departemen Pendidikan dan Kebudayaan PAU Bioteknologi, Universitas Gadjah Mada. Yogyakarta. 20-27.

Giron, M.E., Aguilar, I., Romeura, L., Sanchez, E.E., Perez, J.C., and Rodriguez-Acosta, A. 2005. A Low Cost Method to Test Cytotoxic Effect of Crotalus vegrandis (Viperidae) Venom on Kidney Cell Cultures. Review Instrument of Medical Tropic. 47(3): 147-152.

Doyle, A. , and Griffi th, J.B. 2000. Cells and Tissue Culture for Medical Research. John Willey and Sons Limited. New York.

Mosman, T. 1983. Rapid Colorimetric Assay for Celluler Growth and Survival Application to Proliferation and Cytotoxicity Assays. Journal of Immunology Method. 65: 55 – 63.

Bassilico, N., Pagani, E., Monti, D., Olliaro, P., and Taramelli, D., 1998. A Microtitrebased Method for Measuring The Haem Polimerization Inhibitory Activity (HPIA) of Antimalarial Drugs. Journal of Antimicroba and Chemotherapy. 42: 55-60.

Bohlee, D.S., and Helms, J.B. 1993. Synthesis of Beta-hematin by Dehydrohalogenation of Haem. Biochemical and Biophysical Research Communication. 193 (2): 504 – 508.

Rosenthal, J.P. 1998. Proteases of Malaria Parasites: New Targets for Chemotherapy, Emerging Infectious Diseases. 4(1): 1-8.

Francis, S.E., Sullivan, J.R.D.J., and Goldberg, D.E. 1997. Haemoglobin Metabolism in Malarial Parasites Plasmodium falciparum. Annual Review of Microbiology. 51: 97-123.

Coombs, G. 2001. Aspartic Proteases of Plasmodium falciparum and Other Parasitic Protozoa As Drug Targets. Trends of Parasitology. 17. 532-537.

Ridley, R.G., and Dorn, A. 1997. Haematin (Haem) Polimerization and Its Inhibition by Quinoline Antimalrials. Annual of Tropical Medicine and Parasitology. 91: 559-566.

Yusuf H, Jamil KF, Rinanda T. SEMISINTESIS DAN KARAKTERISASI ANTIMALARIA BARU TURUNAN EURIKUMANON. JKS 2017; 1: 1-7.

Hansch, C., and Leo, A. 1995. Exploring QSAR Fundamental and Applications in Chemistry and Biology. American Chemical Society, Washington, D.C.

Nurlaila, Z., and Kartini, N.O. 2005. Microbiological Characterization of 99mTc-Cyprofloxacin and 99mTc-Ethambutol Labeled Compounds As the Infection Imaging Radiopharmaceuticals. Regional Seminar on Pharmaceuticals and Biomedical Analysis, School of Pharmacy: Bandung, Institut Teknologi Bandung; 15-16 September 2005.

Ferreira, M.C.M. 2002. Multivariate QSAR. Journal of Brazilian Chemical Society. 13(6): 742 – 753.

Published

April 28, 2021

Details about the available publication format: E-Book (Free Selected Page)

E-Book (Free Selected Page)

doi

10.52574/syiahkualauniversitypress.260.327
Themes by Openjournaltheme.com

How to cite